Idiopathic Pulmonary Fibrosis Clinical Trial Using Nintedanib and Matching Placebo

- The folks at Boehringer Ingelheim are studying the effects of Matching Placebo; Nintedanib on Idiopathic Pulmonary Fibrosis in individuals ages 40 years and older. This clinical trial is slated to start November 2013 and is expected to end circa August 2015.

1-800-243-0127
Boehringer Ingelheim Call Center
Overall Study Contact Info
StatusName Contact Phone
RecruitingBoehringer Ingelheim Call Centerclintriage.rdg@boehringer-ingelheim.com1-800-243-0127

This study is officially titled, "A Double Blind Randomized Placebo Controlled Trial Evaluating the Effect of Oral Nintedanib 150 mg Twice Daily on High Resolution Computerized Tomography Quantitative Lung Fibrosis Score, Lung Function, Six Minute Walk Test Distance and St. George's Respiratory Questionnaire After Twelve Months of Treatment in Patients With Idiopathic Pulmonary Fibrosis With Continued Evaluations Over a Period of up to Eighteen Months."

Locations

1199.187.02008 Boehringer Ingelheim Investigational Site

Sherbrooke, Quebec - Recruiting

1199.187.02002 Boehringer Ingelheim Investigational Site

Hamilton, Ontario - Recruiting

1199.187.02007 Boehringer Ingelheim Investigational Site

Vancouver, British Columbia - Recruiting

1199.187.02001 Boehringer Ingelheim Investigational Site

Winnipeg, Manitoba - Recruiting

1199.187.02003 Boehringer Ingelheim Investigational Site

Halifax, Nova Scotia - Recruiting

1199.187.02005 Boehringer Ingelheim Investigational Site

Vancouver, British Columbia - Recruiting

1199.187.01030 Boehringer Ingelheim Investigational Site

Houston, Texas - Not yet recruiting

1199.187.01001 Boehringer Ingelheim Investigational Site

Nashville, Tennessee - Not yet recruiting

1199.187.01012 Boehringer Ingelheim Investigational Site

Charleston, South Carolina - Not yet recruiting

1199.187.01032 Boehringer Ingelheim Investigational Site

Pittsburgh, Pennsylvania - Not yet recruiting

1199.187.01016 Boehringer Ingelheim Investigational Site

Dallas, Texas - Not yet recruiting

1199.187.01027 Boehringer Ingelheim Investigational Site

Philadelphia, Pennsylvania - Not yet recruiting

1199.187.01014 Boehringer Ingelheim Investigational Site

Portland, Oregon - Recruiting

1199.187.01004 Boehringer Ingelheim Investigational Site

Toledo, Ohio - Recruiting

1199.187.02004 Boehringer Ingelheim Investigational Site

Edmonton, Alberta - Recruiting

1199.187.01005 Boehringer Ingelheim Investigational Site

Durham, North Carolina - Not yet recruiting

1199.187.01013 Boehringer Ingelheim Investigational Site

Fridley, Minnesota - Recruiting

1199.187.01006 Boehringer Ingelheim Investigational Site

Los Angeles, California - Not yet recruiting

1199.187.01011 Boehringer Ingelheim Investigational Site

Mineola, New York - Not yet recruiting

1199.187.01008 Boehringer Ingelheim Investigational Site

Lebanon, New Hampshire - Not yet recruiting

1199.187.01023 Boehringer Ingelheim Investigational Site

Chesterfield, Missouri - Not yet recruiting

1199.187.01002 Boehringer Ingelheim Investigational Site

Minneapolis, Minnesota - Recruiting

1199.187.01025 Boehringer Ingelheim Investigational Site

Baltimore, Maryland - Not yet recruiting

1199.187.01024 Boehringer Ingelheim Investigational Site

Baltimore, Maryland - Not yet recruiting

1199.187.01031 Boehringer Ingelheim Investigational Site

Louisville, Kentucky - Not yet recruiting

1199.187.01003 Boehringer Ingelheim Investigational Site

Chicago, Illinois - Not yet recruiting

1199.187.01015 Boehringer Ingelheim Investigational Site

Skokie, Illinois - Recruiting

1199.187.01026 Boehringer Ingelheim Investigational Site

Austell, Georgia - Not yet recruiting

1199.187.01007 Boehringer Ingelheim Investigational Site

Danbury, Connecticut - Recruiting

1199.187.01009 Boehringer Ingelheim Investigational Site

Sarasota, Florida - Recruiting

1199.187.01028 Boehringer Ingelheim Investigational Site

Denver, Colorado - Not yet recruiting

1199.187.01010 Boehringer Ingelheim Investigational Site

Stanford, California - Not yet recruiting

1199.187.01029 Boehringer Ingelheim Investigational Site

San Francisco, California - Not yet recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.